Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jul;10(2):27-30.

Management of diabetic neuropathy

Affiliations

Management of diabetic neuropathy

Raymond Azman Ali. Malays J Med Sci. 2003 Jul.

Abstract

Diabetes mellitus is the commonest cause of neuropathy worldwide. Diabetic neuropathy (DN) develops in about 4-10% of diabetic patients after 5 years and in 15% after 20 years. Four main mechanisms have been postulated to underlie the pathogenesis of DN. Diabetic neuropathy can be divided into symmetrical and asymmetrical neuropathies. Diabetic Autonomic Neuropathy (DAN) parallels the severity of DSN, and affects primarily the cardiovascular, gastrointestinal, genitourinary and integumentary systems. The cornerstone of treatment of diabetic neuropathy is optimization of glycaemic control. Future treatments for diabetic neuropathy should address the underlying pathogenesis.

Keywords: Diabetes Mellitus; Management; Neuropathy.

PubMed Disclaimer

References

    1. Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurgery Psychiatry. 1997;62:310–8. - PMC - PubMed
    1. Bosch EP, Smith BE. Disorders of the Peripheral Nerve. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in Clinical Practice Third Edition. Oxford: Butterworth-Heinemann; 2000. pp. 2045–130.
    1. Thomas PK. Classification, differential diagnosis, and staging of diabetic neuropathy. Diabetes. 1997;46(Suppl 2):S54–S57. - PubMed
    1. Anand P. Neurotrophins and peripheral neuropathy. Phil Trans R Soc London. 1996;351:449–54. - PubMed
    1. Dyck PJ, Giannini C. Pathologic alterations in the diabetic neuropathies of humans: a review. J Neuropathol Exp Neurol. 1997;55:1181–93. - PubMed

LinkOut - more resources